Century Therapeutics vs Kymera Therapeutics
Century Therapeutics is the larger business, with $109m of revenue in fiscal 2025 against $39.2m for Kymera Therapeutics (2.8 times as much). Century Therapeutics grew faster (1556.8% against -16.7%). Century Therapeutics kept more of each dollar of sales as profit: a net margin of -8.8% against -794.0%. Century Therapeutics carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Century TherapeuticsIPSC, 2025 | Kymera TherapeuticsKYMR, 2025 |
|---|---|---|
| Revenue | $109m | $39.2m |
| Revenue growth | 1556.8% | -16.7% |
| Net income | −$9.6m | −$311m |
| Operating margin | -15.8% | -891.1% |
| Net margin | -8.8% | -794.0% |
| Return on equity | -6.0% | -25.8% |
| Free cash flow | −$105m | −$234m |
| Cash | $61.9m | $357m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 78 | 238 |
| Market value | $274m | $10.94bn |
| Price vs our value range | — | — |
| Moat score | — | 14 (Weak) |
| Insider trades, 12 months | 3 buys, 20 sales | 2 buys, 274 sales |